UnitedHealth Group Incorporated is an American for-profit multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers health care products and insurance services.
| Revenue (TTM) | $18.35B |
| Gross Profit (TTM) | $8.17B |
| EBITDA | $2.65B |
| Operating Margin | 9.60% |
| Return on Equity | 19.70% |
| Return on Assets | 7.65% |
| Revenue/Share (TTM) | $303.92 |
| Book Value | $129.21 |
| Price-to-Book | 1.54 |
| Price-to-Sales (TTM) | 0.63 |
| EV/Revenue | 0.965 |
| EV/EBITDA | 6.37 |
| Quarterly Earnings Growth (YoY) | -10.90% |
| Quarterly Revenue Growth (YoY) | 5.30% |
| Shares Outstanding | $51.69M |
| Float | $48.62M |
| % Insiders | 4.98% |
| % Institutions | 106.25% |
Volatility is currently expanding
HCA posted its biggest one-day jump in four years before a single law changed. Wall Street is pricing in relief that needs Congress, a presidential signature, and a December funding fight to survive.
The stocks of big operators in state Medicaid programs, Affordable Care Act markets and hospital groups all jumped.
KING OF PRUSSIA, Pa., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Universal Health Services, Inc. (NYSE: UHS) is scheduled to present at the UBS Global Healthcare Conference on November 10, 2026, at 9:30 a.m.
Universal Health Services NYSE: UHS reported third-quarter adjusted earnings per share of $5.22, down 8% from a year earlier, as the company cited favorable acute-care demand, improving behavioral-health volumes and moderating labor pressures but said results fell below its internal expectations after excluding certain items.
Universal Health Services' Q3 earnings fall 8.3% despite revenue growth, as rising costs and Acute Care pricing pressure offset higher patient volumes.
Universal Health Services, Inc. ( UHS ) Q3 2026 Earnings Call October 28, 2026 8:00 AM EDT Company Participants Darren Lehrich - Vice President of Investor Relations Marc Miller - CEO, President & Director Steve Filton - Executive VP, CFO & Secretary Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Ann Hynes - Mizuho Securities USA LLC, Research Division Justin Lake - Wolfe Research, LLC Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Stephen Baxter - Wells Fargo Securities, LLC, Research Division Kevin Fischbeck - BofA Securities, Research Division Craig Hettenbach - Morgan Stanley, Research Division Jason Cassorla - Guggenheim Securities, LLC, Research Division Andrew Mok - Barclays Bank PLC, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Scott Fidel - Goldman Sachs Group, Inc., Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Sarah James - Cantor Fitzgerald & Co., Research Division Presentation Operator Good day, and thank you for standing by. Welcome to the Q3 2026 Universal Health Services Earnings Conference Call.
Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended September 3 0 , 202 6 and 202 5 : KING OF PRUSSIA, Pa., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $308.7 million, or $5.22 per diluted share, during the third quarter of 2026, as compared to $373.0 million, or $5.86 per diluted share, during the third quarter of 2025.
Universal Health Services' Q3 revenues are expected to rise on higher patient admissions, but surging operating costs and wage pressures could weigh on earnings growth.
Universal Health Services, Inc. is rated Strong Buy due to undervaluation at 8x forward P/E and resilient earnings growth. Recent guidance cuts reflect mostly temporary challenges, with consolidated revenue and EBITDA still growing across both Acute Care and Behavioral Health segments. Medicaid reimbursement cuts are gradual and manageable, with management repositioning toward outpatient behavioral health and private payors.
Universal Health Services (UHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on UHS and any ticker you trade — then tracks every position and per-strategy win rate.
